Stocksigma LogoStocksigma Logo

Amerise Biosciences to Hold 41st AGM; Seeks Approval for WTD & CFO Appointment

Amerise Biosciences (AMERISE) will hold its 41st Annual General Meeting on 24th Sep'26. Key agenda items include adopting the FY26 audited financials and

Amerise Biosciences to Hold 41st AGM; Seeks Approval for WTD & CFO Appointment

Amerise Biosciences Ltd 路 Annual General Meeting 路 01 Sept 2026, 10:10 pm

Amerise Biosciences to Hold 41st AGM; Seeks Approval for WTD & CFO Appointment Amerise Biosciences (AMERISE) will hold its 41st Annual General Meeting on 24th Sep'26. Key agenda items include adopting the FY26 audited financials and seeking shareholder approval for the appointment of Mr. Albert Hines as Whole Time Director (WTD) & Chief Financial Officer (CFO). The appointment is effective from 02nd Feb'26 for a three-year term with nil remuneration. The record date for e-voting eligibility is 17th Sep'26. The Register of Members will be closed from 17th Sep'26 to 24th Sep'26.

Original exchange filing (PDF)

More announcements from Amerise Biosciences Ltd

All Amerise Biosciences Ltd announcements